Kestra Medical Technologies, Lt (KMTS): Valuation
TTM figures as of April 30, 2026
Kestra Medical Technologies, Lt trades at a -8.71% free-cash-flow yield.
Earnings yield -9.83%. ROIC -100.5%. Piotroski F-score 5 of 9. Net cash $153.8M.
17 month-end valuation observations are on file, starting April 2025.
Sector comparison uses 2682 Healthcare names.
Frequently asked questions
Is KMTS cheap versus its own history?
Kestra Medical Technologies, Lt trades at a -8.71% free-cash-flow yield.
What is KMTS's free-cash-flow yield?
Kestra Medical Technologies, Lt currently yields -8.71% of market cap as trailing free cash flow.
Where do these valuation figures come from?
Yields and quality metrics are computed from the same SEC TTM figures as the financials page, against the live market cap. Historical bands reconstruct month-end market cap from split-adjusted closes and the share count in the units it was filed, then divide by those dollar totals. Nothing here is a third-party estimate.